Helsinki, Finland, 16 November 2023: Charles MacBain, the CEO and a primary
insider of Nordhealth AS (the "Company"), has today purchased 1,948,077 class A
shares in the Company at a price of NOK 23.50 per share.

Following the transaction, Charles MacBain owns 7,423,823 class A shares in the
Company. In addition, he holds 4,904,387 class A shares and 29,794,638 class B
shares, in total 34,699,025 shares indirectly, through Three Plus Group
Luxembourg SA.

Please refer to the attached notification of trading for further details.

For further information, please contact:

Charles MacBain, CEO

charles.macbain@nordhealth.com

+44 75 3903 2200

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 380
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.comÂ (http://www.nordhealth.com).